• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发 HLA-DQ 表位免疫原性评分:概念研究。

Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

机构信息

Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.

Transplantation Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.

出版信息

HLA. 2021 Jan;97(1):30-43. doi: 10.1111/tan.14110. Epub 2020 Oct 28.

DOI:10.1111/tan.14110
PMID:33068062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7756751/
Abstract

Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA-DQ eplets in a cohort of 221 pregnancies with HLA-DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child-specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA-DQ eplets and created a map of potentially immunogenic regions on HLA-DQ molecules, which requires validation in clinical transplant cohorts.

摘要

表位是指 HLA 分子表面上独特的氨基酸构型。本研究的目的是在 221 例 HLA-DQ 错配的妊娠队列中估计 HLA-DQ 表位的免疫原性。我们通过针对它的抗体反应频率来定义表位的免疫原性。大约 90%的所有列出的 DQB1 或 DQA1 表位至少有五倍错配,因此包括在计算它们的免疫原性中。免疫原性评分最高的五个 DQB1 表位是 55PP、52PR、52PQ、85VG 和 45EV;25%的 DQB1 表位没有反应。免疫原性评分最高的五个 DQA1 表位是 25YS、47QL、55RR、187T 和 18S;17%的 DQA1 表位没有反应。免疫原性评分预测儿童特异性抗体的发展比各种分子错配评分(例如表位错配负荷、氨基酸错配负荷)具有略高的曲线下面积。重叠表位被确定为根据 HLA 抗体反应模式明确分配免疫原性评分的障碍。在这项概念研究中,我们探索了 HLA-DQ 表位的免疫原性,并创建了 HLA-DQ 分子上潜在免疫原性区域的图谱,这需要在临床移植队列中进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/8e25396adf5d/TAN-97-30-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/0602e6676e3c/TAN-97-30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/b04e7e4a318c/TAN-97-30-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/2076da0b552f/TAN-97-30-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/2e087da83e5b/TAN-97-30-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/8e25396adf5d/TAN-97-30-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/0602e6676e3c/TAN-97-30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/b04e7e4a318c/TAN-97-30-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/2076da0b552f/TAN-97-30-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/2e087da83e5b/TAN-97-30-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20b/7756751/8e25396adf5d/TAN-97-30-g005.jpg

相似文献

1
Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.开发 HLA-DQ 表位免疫原性评分:概念研究。
HLA. 2021 Jan;97(1):30-43. doi: 10.1111/tan.14110. Epub 2020 Oct 28.
2
HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.HLA-DQ 特异性重组人单克隆抗体可深入分析 HLA-DQ 表位。
Front Immunol. 2022 Jan 7;12:761893. doi: 10.3389/fimmu.2021.761893. eCollection 2021.
3
Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.迈向定义HLA表位的免疫原性:HLA I类表位对孕期抗体形成的影响。
HLA. 2020 Nov;96(5):589-600. doi: 10.1111/tan.14054. Epub 2020 Sep 10.
4
Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.肾移植后由供体特异性 HLA-DQB1 和 DQA1 抗体介导的排斥反应:一例报告
Transplant Proc. 2020 Jul-Aug;52(6):1931-1936. doi: 10.1016/j.transproceed.2020.02.127. Epub 2020 May 19.
5
Characterisation of the HLA-DQ alpha eplet 52SK targeting the DQA1*01 alleles family.鉴定 HLA-DQα 表位 52SK 与 DQA1*01 等位基因家族的结合情况。
HLA. 2024 Oct;104(4):e15700. doi: 10.1111/tan.15700.
6
Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.肾移植后因供体特异性 HLA-DQA1 抗体导致的抗体介导的排斥反应:一例报告。
Transpl Immunol. 2022 Aug;73:101607. doi: 10.1016/j.trim.2022.101607. Epub 2022 Apr 25.
7
Highly Immunogenic DQB1 Mismatch Eplets Are Associated With Development of Chronic Active Antibody-Mediated Rejection: A First Report From Japan.高免疫原性DQB1错配表位与慢性活动性抗体介导的排斥反应的发生相关:来自日本的首例报告。
Transplant Proc. 2017 Jan-Feb;49(1):84-87. doi: 10.1016/j.transproceed.2016.10.022.
8
Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.通过人源单克隆 HLA 抗体对抗原决定簇进行 HLA Ⅰ类和Ⅱ类抗体验证。
HLA. 2024 Jan;103(1):e15345. doi: 10.1111/tan.15345.
9
Case report: binding of a clinically relevant human leukocyte antigen-DQα-specific antibody in a kidney graft recipient is inhibited by donor-type human leukocyte antigen-DQβ chain.病例报告:肾移植受者中一种临床相关的人类白细胞抗原 - DQα特异性抗体的结合被供体型人类白细胞抗原 - DQβ链抑制。
Transplant Proc. 2013 Apr;45(3):1209-12. doi: 10.1016/j.transproceed.2012.10.006.
10
Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.再次移植候选者具有与结构明确的人类白细胞抗原-DR、-DQ、-DP表位发生反应的供者特异性抗体。
Transpl Immunol. 2008 Feb;18(4):352-60. doi: 10.1016/j.trim.2007.10.001. Epub 2007 Oct 30.

引用本文的文献

1
Variations in de novo donor-specific antibody development among HLA-DQ mismatches in kidney transplant recipients.肾移植受者中HLA-DQ错配间新生供者特异性抗体产生的差异。
PLoS One. 2025 Apr 15;20(4):e0321629. doi: 10.1371/journal.pone.0321629. eCollection 2025.
2
Understanding HLA-DQ in renal transplantation: a mini-review.肾移植中对人类白细胞抗原-DQ的理解:一篇综述短文
Front Immunol. 2025 Feb 5;16:1525306. doi: 10.3389/fimmu.2025.1525306. eCollection 2025.
3
epiArt: a graphical HLA eplet amino acid repertoire translation reveals the need for an epitope driven revision of allele group nomenclature.

本文引用的文献

1
Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.迈向定义HLA表位的免疫原性:HLA I类表位对孕期抗体形成的影响。
HLA. 2020 Nov;96(5):589-600. doi: 10.1111/tan.14054. Epub 2020 Sep 10.
2
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.移植中的致敏:风险评估(STAR)2019 工作组会议报告。
Am J Transplant. 2020 Oct;20(10):2652-2668. doi: 10.1111/ajt.15937. Epub 2020 May 27.
3
Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR.
EpiArt:一种图形化的HLA表位氨基酸库翻译揭示了基于表位驱动修订等位基因组命名法的必要性。
Front Genet. 2024 Oct 16;15:1449301. doi: 10.3389/fgene.2024.1449301. eCollection 2024.
4
High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation.高危 HLA-DQ 错配与肺移植后不良结局相关。
Transpl Int. 2024 Sep 19;37:13010. doi: 10.3389/ti.2024.13010. eCollection 2024.
5
A Short History of B-Cell HLA Epitopes.B细胞HLA表位简史
Transfus Med Hemother. 2024 Apr 22;51(3):152-157. doi: 10.1159/000538447. eCollection 2024 Jun.
6
Homozygosity in any HLA locus is a risk factor for specific antibody production: the taboo concept 2.0.任何 HLA 基因座的纯合子都是特定抗体产生的风险因素:禁忌概念 2.0。
Front Immunol. 2024 May 22;15:1384823. doi: 10.3389/fimmu.2024.1384823. eCollection 2024.
7
Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation.贝伐珠单抗联合限时他克莫司免疫抑制可改变肾移植 3 年内供者特异性抗体错配的风险。
Am J Transplant. 2024 Feb;24(2):260-270. doi: 10.1016/j.ajt.2023.09.011. Epub 2023 Sep 29.
8
DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation.DQA1表位错配负荷作为肺移植后慢性肺移植功能障碍的独立危险因素
Transplant Direct. 2023 Jun 28;9(7):e1513. doi: 10.1097/TXD.0000000000001513. eCollection 2023 Jul.
9
Progress in kidney transplantation: The role for systems immunology.肾移植的进展:系统免疫学的作用
Front Med (Lausanne). 2022 Dec 16;9:1070385. doi: 10.3389/fmed.2022.1070385. eCollection 2022.
10
Snowflake epitope matching correlates with child-specific antibodies during pregnancy and donor-specific antibodies after kidney transplantation.雪片表位匹配与妊娠期间的儿童特异性抗体和肾移植后的供体特异性抗体相关。
Front Immunol. 2022 Oct 28;13:1005601. doi: 10.3389/fimmu.2022.1005601. eCollection 2022.
针对HLA - DR表位的人重组单克隆抗体的产生及反应性分析
Am J Transplant. 2020 Dec;20(12):3341-3353. doi: 10.1111/ajt.15950. Epub 2020 May 15.
4
Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.不同的表位软件程序给出不一致且错误的结果:HLAMatchmaker与Fusion Matchmaker表位调用软件的分析
HLA. 2020 Jul;96(1):52-63. doi: 10.1111/tan.13897. Epub 2020 Apr 26.
5
HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level.HLA-EMMA:一种在氨基酸水平分析HLA I类和II类兼容性的用户友好型工具。
HLA. 2020 Jul;96(1):43-51. doi: 10.1111/tan.13883. Epub 2020 Apr 13.
6
The quest to decipher HLA immunogenicity: Telling friend from foe.解析 HLA 免疫原性之谜:辨别敌我。
Am J Transplant. 2019 Oct;19(10):2910-2925. doi: 10.1111/ajt.15489. Epub 2019 Jul 8.
7
Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.表位负荷可识别出在减少免疫抑制后发生同种异体致敏风险的肾移植受者。
Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.
8
Towards the identification of the relative immunogenicity of individual HLA antibody epitopes.迈向个体HLA抗体表位相对免疫原性的鉴定。
Hum Immunol. 2019 Apr;80(4):218-220. doi: 10.1016/j.humimm.2019.02.002. Epub 2019 Feb 5.
9
Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database.国际HLA表位登记处的第二次更新。I. HLA-ABC表位数据库。
Hum Immunol. 2019 Feb;80(2):103-106. doi: 10.1016/j.humimm.2018.11.007. Epub 2018 Nov 17.
10
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.HLA-DR/DQ 分子错配:原发性同种异体免疫的预后生物标志物。
Am J Transplant. 2019 Jun;19(6):1708-1719. doi: 10.1111/ajt.15177. Epub 2018 Dec 15.